MedPath

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

Completed
Conditions
Melanoma
Breast Cancer
Lymphoma
Ovarian Cancer
Prostate Cancer
Registration Number
NCT00001503
Lead Sponsor
National Cancer Institute (NCI)
Brief Summary

This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.

Detailed Description

Background:

* Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy.

* Keeping the primary treatment protocols open after accrual is complete in order to follow patients for long term outcome is an administrative burden on investigators and the IRB.

Objectives:

-To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol.

Eligibility:

-Patients who were previously enrolled on a CCR protocol and who are not eligible for an active NCI intramural primary research protocol.

Design:

* The medical procedures/tests will be based on the patient's diagnosis, treatment and supporting clinical information. This is a follow-up study in which only standard tests and procedures are to be performed.

* Clinical information that is relevant to the patients prior protocols will be collected for research purposes.

* Procedures that entail more than minimal risk to the patient should not be performed for research purposes on this protocol.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1031
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol30 years

Provision of a mechanism to follow selected CCR patients when their protocols have been terminated.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Institutes of Health Clinical Center

🇺🇸

Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath